JAZZ vs UNIT · P/E 1988, rev $4.07B vs P/E 2.7, rev $722.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the JAZZ and UNIT stock pages for the full models.
Not investment advice.